Key result
The mean direct costs of warfarin treatment for atrial fibrillation patients were 589.82 Euros per patient (95% CI: 586.68-591.99), with costs significantly higher for those not in INR-balance.
Why the study?
What are the direct costs of warfarin treatment and the impact of INR control on these costs in older patients with atrial fibrillation?
Population
250 atrial fibrillation patients aged 65 years or older receiving warfarin treatment in a Finnish communal…
Design
Cohort
Follow-up
12 months
Authors
Loading...
Poor INR control may raise warfarin costs in older AF; leaves open whether optimized monitoring improves economic outcomes.
Cohort (n=250)
No
What are the direct costs of warfarin treatment and the impact of INR control on these costs in older patients with atrial fibrillation?
Poor INR control significantly increases the direct healthcare costs of warfarin treatment in older patients with atrial fibrillation.
Hallinen et al. (2006) conducted a cohort in atrial fibrillation (n=250). Warfarin treatment was evaluated on mean direct costs of warfarin treatment (95% CI 586.68-591.99). The mean direct costs of warfarin treatment for atrial fibrillation patients were 589.82 Euros per patient (95% CI: 586.68-591.99), with costs significantly higher for those not in INR-balance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: